Cargando…

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum

Detalles Bibliográficos
Autores principales:	Liu, Qianjiao, Nie, Hongfang, Xu, Hengtian, Wang, Pingxian, Lei, Pinggui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Radiology 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772382/ https://www.ncbi.nlm.nih.gov/pubmed/32767866 http://dx.doi.org/10.3348/kjr.2020.0492

Ejemplares similares

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Spontaneous Pneumomediastinum in a Patient with Coronavirus Disease 2019 Pneumonia and the Possible Underlying Mechanism
por: Lei, Pinggui, et al.
Publicado: (2020)

Diagnostic efficiency on ultrasound shear wave elastography in evaluation of steatosis severity for non-alcoholic fatty liver disease: a rat model
por: Wu, Yuhui, et al.
Publicado: (2023)

Key Considerations for Radiologists When Diagnosing the Novel Coronavirus Disease (COVID-19)
por: Lei, Pinggui, et al.
Publicado: (2020)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease, diabetes medications and blood pressure
por: Ilias, Ioannis, et al.
Publicado: (2021)

Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Jeong, Seogsong, et al.
Publicado: (2023)

Multipronged Approach to Assess Risk Factors for Non-alcoholic Fatty Liver Disease
por: Hidrus, Aizuddin, et al.
Publicado: (2022)

Comments on Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran
por: Karimi-Sari, H., et al.
Publicado: (2017)

Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
por: Abbas, Tahany, et al.
Publicado: (2020)

Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease
por: Liu, Dong, et al.
Publicado: (2022)

Noninvasive Methods to Evaluate Liver Fibrosis in Chronic HCV Infection
por: El-Shabrawi, Mortada Hassan, et al.
Publicado: (2011)

Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies
por: Lu, Li-Yu, et al.
Publicado: (2022)

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2019)

Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
por: Patoulias, Dimitrios, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
por: Jeong, Seogsong, et al.
Publicado: (2022)

The progression of computed tomographic (CT) images in patients with coronavirus disease (COVID-19) pneumonia: Running title: The CT progression of COVID-19 pneumonia
por: Lei, Pinggui, et al.
Publicado: (2020)

Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2018)

Noninvasive imaging in the diagnosis of acute viral myocarditis
por: Jeserich, Michael
Publicado: (2010)

Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Hye Won
Publicado: (2023)

COVID-19 Carrier or Pneumonia: Positive Real-Time Reverse-Transcriptase Polymerase Chain Reaction but Negative or Positive Chest CT Results
por: Lei, Pinggui, et al.
Publicado: (2020)

Is Ki-67 a prognostic factor for post-operation survival in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma?
por: Li, Changcan, et al.
Publicado: (2022)

Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Multiple parameters required for diagnosis of COVID-19 in clinical practice
por: Lei, Pinggui, et al.
Publicado: (2020)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
por: Lee, Dae Ho
Publicado: (2020)

Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
por: Lee, Dong Ho
Publicado: (2017)

Noninvasive cardiac imaging for the diagnosis of coronary artery disease in women
por: Kıraç, F. Suna
Publicado: (2015)

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
por: Govaere, Olivier, et al.
Publicado: (2023)

Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia
por: Meroni, Marica, et al.
Publicado: (2022)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
por: Adler, Michael
Publicado: (2011)

The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases
por: Kaya, Eda, et al.
Publicado: (2020)

Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease
por: Gruneau, Lina, et al.
Publicado: (2023)

Urinary lithogenic profile of patients with non-alcoholic fatty liver disease
por: Bargagli, Matteo, et al.
Publicado: (2023)

Acute Fatty Liver of Pregnancy
por: Dey, Madhusudan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k5d4ndb5kqspcl7902avf564h6